Activity of abundant antimicrobials of the human airway

American Journal of Respiratory Cell and Molecular Biology

Volumn 20, Issue 5, 1999, Pages 872-879

  Travis, Sue M ^a   Conway, Barbara Ann D ^a   Zabner, Joseph ^a   Smith, Jeffrey J ^a   Anderson, Norma N ^a   Singh, Pradeep K ^a   Greenberg, E Peter ^a   Welsh, Michael J ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BURKHOLDERIA;

ANTIINFECTIVE AGENT; MUCIN; PANCREATIC ELASTASE; SODIUM CHLORIDE;

ARTICLE; CYSTIC FIBROSIS; DRUG ANTAGONISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LUMINESCENCE; METABOLISM; MICROBIOLOGY; OSMOLARITY; PHYSIOLOGY; TRACHEA;

ANTI-INFECTIVE AGENTS; CYSTIC FIBROSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LUMINESCENT MEASUREMENTS; MUCINS; OSMOLAR CONCENTRATION; PANCREATIC ELASTASE; SODIUM CHLORIDE; TRACHEA;

EID: 0033128302     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.20.5.3572     Document Type: Article

References (50)

1. Fleming, A. 1922. On a remarkable bacteriolytic element found in tissues and secretions. Proc. R. Soc. Lond. B. Biol. Sci. 93-306-317.
2. Basbaum, C. B., B. Jany, and W. E. Einkbieiner. 1990. The serous cell. Annu. Rev. Physiol. 52:97-113.
3. Raphael, G. D., E. V. Jeney, J. N. Baraniuk, I. Kim, S. D. Meredith, and M. A. Kaliner. 1989. Pathophysiology of rhinitis. J. Clin. Invest. 84:1528-1535.
4. Thompson, A. B., T. Bohling, F. Payvandi, and S. I. Rennard. 1990. Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis. J. Lab. Clin. Med. 115:148-158.
5. Brogan, T. D., H. C. Ryley, L. Neale, and J. Yassa. 1975. Soluble proteins of bronchopulmonary secretions from patients with cystic fibrosis, asthma, and bronchitis. Thorax 30:72-79.
6. Kotlar, H. K., O. Harbitz, A. O. Jenssen, and O. Smidsrod. 1980. Quantitation of proteins in sputum from patients with chronic obstructive lung disease. Eur. J. Respir. Dis. 61:233-239.
7. Harbitz, O., A. O. Jenssen, and O. Smidsrod. 1984. Lysroyme and lactoferrin in sputum from patient with chronic obstructive lung disease. Eur. J. Respir. Dis. 65:512-520.
8. Jacquot, J., J. M. Tournier, T. G. Carmona, E. Puchelle, J. P. Chazalette, and P. Sadoul. 1983. Proteins of bronchial secretions in mucoviscidosis: role of infection. Bull. Eur. Physiopathol. Respir. 19:453-458.
9. Arnold, R. R., M. Brewer, and J. J. Gauthier. 1980. Bactericidal activity of human lactoferrin: sensitivily of a variety of microorganisms, Infect. Imnum. 28:893-898.
10. Hutchison, D. C. S. 1987. The role of proteases and antiproteases in bronchial secretions. Eur. J. Respir. Dus. 71(Suppl. 153):78-85.
11. Hiemstra, P. S., R. J. Maassen, J. Stolk, R. Heinzel-Wieland, G. J. Steffens, and J. H. Dijkman. 1996. Antibacterial activity of antileukoprotease. Infect. Immun. 64:4520-4524.
12. Vogelmeier, C., R. C. Hubbard, G. A. Fells, H.-P. Schnebli, R. C. Thompson, H. Fritz, and R. G. Crystal. 1991. Anti-neutrophil clastase defense of the normal human respiratory epithelial surface provided by the secretory leukoproteasc inhibitor. J. Clin. Invest. 87:482-488.
13. Kouchi, I., S. Yasuoka, Y. Ueda, and T Ogura. 1993. Analysis of secretory leukocyte protease inhibitor (SLPI) in bronchial secretions from patients with hypersecretory respiratory diseases. Tokushima J. Exp., Med. 40:95-107.
14. Lee, C. H., Y. Igarashi, R. J. Hohman, H. Kaulbach, M. V. White, and M. A. Kaliner. 1993. Distribution of secretory leukoprotease inhibitor in the human nasal airway. Am. Rev. Respir. Dis. 147:710-716.
15. Zhao, C., I. Wang, and R. I. Lehrer. 1996. Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett. 396:319-322.
16. McCray, P. B., Jr., and L. Bentley. 1997. Human airway epithelia express a β-defensin. Am. J. Rispir. Cell Mol. Biol. 16:343-349.
17. Goldman, M. J., G. M. Anderson, E. D. Stolzenberg, U. P. Kari, M. Zasloff, and J. M. Wilson. 1997. Human β-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88:553-560.
18. Bals, R., X. Wang, Z. Wu, T. Freeman, V. Bafna, M. Zasloff, and J. M Wilson. 1998. Human β-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J. Clin. Invest. 102:874-880.
19. Diamond, G., and C. L. Bevins. 1998. Beta-defensins: endogenous antibiotics of the innate host defense response. Clin. Immunol. Immunopathol. 88:221-225.
20. Singh, P. K., H. P. Jia, K. Wiles, J. Hesselberth, I. Liu, B.-A. D. Conway, E. P. Greenberg. E. V. Valore, M. J. Welsh, T. Ganz, B. F. Tack, and P. B. McCray, Jr. 1998. Production of β-defensins by human airway epithelia. Proc. Natl. Acad. Sci. USA 95:1461-14966.
21. Bals, R., X. Wang, M. Zasloff, and J. M. Wilson. 1998. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc. Natl. Acad. Sci. USA 95:9541-9546.
22. Gilligan, P. H. 1991. Microbiology of airway disease in patients with cystic fibrosis. Clin. Microbiol. Rev. 4:35-51.
23. Smith, J. J., S. M. Travis, E. P. Greenberg, and M. J. Welsh. 1996. Cystic librosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85:229-236.
24. Wine, J. J. 1997. A sensitive defense: salt and cystic fibrosis. Nat. Med. .3:494-495.
25. Davies, R. C., A. Neuberger, and B. M. Wilson. 1969. The dependence of lysozyme activity on pH and ionic strength. Biochim. Biophys. Acta 178: 294-305.
26. Millar, M. 1987. The susceptibility to lysozyme of β-lactamase-producing and non-producing derivatives of Staphylococcus aureus strain 1030. J. Med. Microbiol. 23:127-132.
27. Valore, E. V., C. H. Park, A. J. Quayle, K. R. Wiles, P. B. McCray, Jr., and T. Ganz. 1998. Human β-defensin-1: an antimicrobial peptide of urogenital tissues. J. Clin. Invest. 101:1633-1642
28. Knowles, M. R., J. M. Robinson, R. E. Wood, C. A. Pue, W. M. Mentz, G. C. Wager, J. T. Gatzy, and R. C. Boucher. 1997. Ion composition of airway surface liquid of patients with cystic fibrosis as compared wilh normal and disease-control subjects. j. CLIN. Invets 100:2588-2595.
29. Hull, J., W. Skinner, C. Robertson, and P. Phelan. 1998. Elemental content of airway surface liquid from infants with cystic fibrosis. Am. J. Respir. Crit. Care Med. 157:10-14.
30. Erjefält, I., and C. G. A. Persson. 1990. On the use of absorbing dises to sample mucosal surface liquids. Clin. Exp, Allergy 20:193-197.
31. Joris, L., I. Dab, and P. M. Quinton, 1993, Elemental composition of human airway surface fluid in healthy and diseased airways. Am. Rev. Respir. Dis. 148:1633-1637.
32. Gilljam, H., A. Ellin, and B. Strandvik, 1989. Increased bronchial chloride concentration in cystic fibrosis. Scand. J. Clin. Lab. Invest. 49:121-124.
33. Zabnet, J., J. J. Smith, P. H. Karp, J. H. Widdicombe, and M. J. Welsh. 1998, Loss of CFTR chloride channels alters salt absorption by cystic fibrosis airway epithelia in vitro. Mol. Cell. 2:397-403.
34. Wilsher, M. L., I. Kolbe, A. J. Morris, and D. F. Welch. 1997. Nosocomial acquisition of Burkholderia gladioli in patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 155:1436-1440.
35. Barker, P. M., R. E. Wood, and P. H. Gilligan. 1997, Lung infection with Burkholderia gladioli in a child with cystic fibrosis: acute clinical and spirometric deterioration. Pediatr. Pulmonol. 23:123-125.
36. Szittner, R., and E. Meighen. 1990. Nucleotide sequence, expression, and properties of lueiferase coded by lux genes from a terrestrial bacterium. J. Biol. Chem. 265:16581-16587.
37. Frackrnan, S., M. Anhalt, and K. H. Nealson. 1990. Cloning, organization, and expression of the bioluminescence genes of Xenorhabdus luminescens. J. Barteriol. 172:5767-5773.
38. Rennard, S. I., G. Basset, D. Lecossier, K. M. O'Donnell. P. Pinkston. P. G. Martin, and R. G. Crystal. 1998. Estimation of volume of epithelial lining fluid recovered by lavage using urea as a marker of dilution. J. Appl. Physsiol. 60:532-538.
39. Kaulbach, H. C., M. V. White, Y. Igarashi, B. K. Hahn, and M. A. Kaliner. 1993. Estimation of nasal epithelial lining fluid using urea as a marker. J. Allergy Clin. Immunol. 92:457-465.
40. Thompson, A. B., M. B. Mueller. A. J. Heires, T. I., Bohling, D. Daughton. S. W. Yancey. R. S. Sykes, and S. I. Rennard, 1992. Aerosolized beclometh asone in chronic bronchitis. Ant. Rev. Respir. Dis. 146:389-395.
41. Govan, J. R. W., J. F., Hughes, and P. Vandamme. 1996. Burkholderia cepacia: medical, taxonomic and ecological issues. J. Med. Mirobiol. 45:395-407.
42. Ganz, T., and R. I. Lehrer. 1995. Defensins. Pharmacol. Ther. 66:191 205.
43. Hancock, R. E. W. 1984. Alterations in outer membrane permeability. Annu. Rev. Microbiol. 38:237-264.
44. Jacquol, J., J.-M. Tournier, and E. Puchelle. 1985. In vitro evidence that human airway lysozyme is cleaved and inactivated by Pseudomonas aeruginosa elastase and not by human leukocyte elastase. Infect. Immun. 47: 555-560.
45. Britigan, B. E., M. B. Hayek, B. N. Doebbeling, and R. B. Fiek, Jr. 1993. Transferrin and lactoferrin undergo proteolytic cleavage in the Pseudomonas aeruginosa-infected lungs of patients with cystic fibrosis. Infect. Immun. 61:5049-5055.
46. Belaaouaj, A., R. McCarthy, M. Baumann, Z. Gao, T. J. Ley, S. N. Abraham, and S. D. Shapini. 1998. Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nat. Med. 4: 615-618.
47. Gawel, J., J. Rudnik, J. Pryjma, J. Zebrak, J. Haluszka, I. Rudnik, and H. Majewska-Zalewska, 1979. Proteins in bronchial secretion of children with chronic pulmonary diseases: I. Relation to clinical diagnosis. Scand. J. Respir. Dis. 60:63-68.
48. Zebrak, J., T. Herman, R. Werys, J. Pryjma, and J. Gawel. 1979. Proteins in bronchial secretion of children with chronic pulmonary diseases: II Relation to bronchoscopic and bronchographic examination. Scand. J. Respir. Dis. 60:69-75.
49. Schnapp, D., and A. Harris, 1998. Antibacterial peptides in bronchoalveolar lavage fluids. Am. J. Respir. Cell Mol. Biol. 19:352-356.
50. Harwig, S. S. L., A. Waring, H. J. Yang, Y. Oho, L. Tan, and R. I. Lehrer. 1996. Intramolecular disulfide bonds enhance the antimicrobial and lytic activities of protegrins at physiological sodium chloride concentrations. Eur. J. Biochem. 240:352-357.